%0 Journal Article
%T Naming the drugs we use: neuroscience-based nomenclature, a helpful innovation
%A Sue Wilson
%J Archive of "Therapeutic Advances in Psychopharmacology".
%D 2018
%R 10.1177/2045125318762065
%X Many of the drugs we use in psychiatry are referred to by outdated or confusing names, for instance ¡®second generation¡¯ (or worse still, ¡®atypical¡¯) antipsychotic, or terms such as ¡®noradrenergic and specific serotonergic antidepressants¡¯ and ¡®noradrenergic reuptake inhibitors¡¯ for drugs for depression. Moreover, new drugs that are developed are referred to according to these disorder-based categories and then found to be effective in another disorder. Sometimes drugs called ¡®antipsychotics¡¯ are prescribed in bipolar disorder and those called ¡®antidepressants¡¯ are routinely prescribed for anxiety disorders. This causes confusion for patients and may affect adherence
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956643/